{"disease":{"id":"idiopathic-hyperaldosteronism","name":"idiopathic hyperaldosteronism"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07328230","title":"Superselective Adrenal Arterial Embolization Versus Oral Spironolactone for Treatment of Idiopathic Hyperaldosteronism","phase":"NA","overall_status":"RECRUITING","enrollment_count":172,"lead_sponsor_name":"Chinese Academy of Medical Sciences, Fuwai Hospital","has_results":false},{"nct_id":"NCT07027254","title":"PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism","phase":"NA","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT05826080","title":"Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary Aldosteronism","phase":"","overall_status":"UNKNOWN","enrollment_count":59,"lead_sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}